Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $60.13 million. The enterprise value is $63.43 million.
| Market Cap | 60.13M |
| Enterprise Value | 63.43M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 140.26 million shares outstanding. The number of shares has increased by 9.82% in one year.
| Current Share Class | 140.26M |
| Shares Outstanding | 140.26M |
| Shares Change (YoY) | +9.82% |
| Shares Change (QoQ) | -6.91% |
| Owned by Insiders (%) | 12.53% |
| Owned by Institutions (%) | 13.83% |
| Float | 54.29M |
Valuation Ratios
The trailing PE ratio is 38.96.
| PE Ratio | 38.96 |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| Forward PS | 0.56 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | 7.74 |
| P/OCF Ratio | 6.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.95, with an EV/FCF ratio of 8.16.
| EV / Earnings | 34.74 |
| EV / Sales | 0.52 |
| EV / EBITDA | 7.95 |
| EV / EBIT | 19.23 |
| EV / FCF | 8.16 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.32.
| Current Ratio | 3.34 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.93 |
| Debt / FCF | 1.99 |
| Interest Coverage | 1.02 |
Financial Efficiency
Return on equity (ROE) is 3.95% and return on invested capital (ROIC) is 2.69%.
| Return on Equity (ROE) | 3.95% |
| Return on Assets (ROA) | 2.37% |
| Return on Invested Capital (ROIC) | 2.69% |
| Return on Capital Employed (ROCE) | 5.57% |
| Weighted Average Cost of Capital (WACC) | 4.68% |
| Revenue Per Employee | $807,331 |
| Profits Per Employee | $12,093 |
| Employee Count | 151 |
| Asset Turnover | 1.40 |
| Inventory Turnover | 1.30 |
Taxes
In the past 12 months, XTNT has paid $2.08 million in taxes.
| Income Tax | 2.08M |
| Effective Tax Rate | 53.25% |
Stock Price Statistics
The stock price has decreased by -32.82% in the last 52 weeks. The beta is -0.16, so XTNT's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | -32.82% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.59 |
| Relative Strength Index (RSI) | 46.58 |
| Average Volume (20 Days) | 97,191 |
Short Selling Information
The latest short interest is 70,049, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 70,049 |
| Short Previous Month | 1,568 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 0.68 |
Income Statement
In the last 12 months, XTNT had revenue of $121.91 million and earned $1.83 million in profits. Earnings per share was $0.01.
| Revenue | 121.91M |
| Gross Profit | 76.00M |
| Operating Income | 3.30M |
| Pretax Income | 3.91M |
| Net Income | 1.83M |
| EBITDA | 7.98M |
| EBIT | 3.30M |
| Earnings Per Share (EPS) | $0.01 |
Balance Sheet
The company has $12.14 million in cash and $15.44 million in debt, with a net cash position of -$3.30 million or -$0.02 per share.
| Cash & Cash Equivalents | 12.14M |
| Total Debt | 15.44M |
| Net Cash | -3.30M |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 48.60M |
| Book Value Per Share | 0.35 |
| Working Capital | 43.85M |
Cash Flow
In the last 12 months, operating cash flow was $9.15 million and capital expenditures -$1.39 million, giving a free cash flow of $7.77 million.
| Operating Cash Flow | 9.15M |
| Capital Expenditures | -1.39M |
| Depreciation & Amortization | 4.68M |
| Net Borrowing | -21.72M |
| Free Cash Flow | 7.77M |
| FCF Per Share | $0.06 |
Margins
Gross margin is 62.34%, with operating and profit margins of 2.71% and 1.50%.
| Gross Margin | 62.34% |
| Operating Margin | 2.71% |
| Pretax Margin | 3.20% |
| Profit Margin | 1.50% |
| EBITDA Margin | 6.55% |
| EBIT Margin | 2.71% |
| FCF Margin | 6.37% |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.82% |
| Shareholder Yield | -9.82% |
| Earnings Yield | 3.04% |
| FCF Yield | 12.92% |
Analyst Forecast
The average price target for XTNT is $1.35, which is 214.91% higher than the current price. The consensus rating is "Buy".
| Price Target | $1.35 |
| Price Target Difference | 214.91% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -2.89% |
| EPS Growth Forecast (3Y) | 10.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
XTNT has an Altman Z-Score of -0.44 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.44 |
| Piotroski F-Score | 8 |